Bristol-Myers Squibb (BMY) Tops Q1 EPS by 28c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads gains as SpaceX, Super Micro results improve AI appetite
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- AI bubble about to burst? Not yet, Yardeni says
- SpaceX tops Q3 estimates as revenue surges 161% on Starlink, AI compute expansion
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $61.19 -0.79%
EPS Growth %: -33.1%
Financial Fact:
Research and development: 1.14B
Today's EPS Names:
OMID, BCML, CZNC, More
EPS Growth %: -33.1%
Financial Fact:
Research and development: 1.14B
Today's EPS Names:
OMID, BCML, CZNC, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of $1.80, $0.28 better than the analyst estimate of $1.52. Revenue for the quarter came in at $11.2 billion versus the consensus estimate of $10.68 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2025 EPS of $6.70-$7.00, versus the consensus of $6.74. Bristol-Myers Squibb sees FY2025 revenue of $45.8-46.8 billion, versus the consensus of $45.76 billion.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays cuts Cirrus Logic price target to $95 from $130, cuts to Underweight
- First Community Corp. (FCCO) Tops Q3 EPS by 5c
- Appian stock rises amid software sector rally
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
